Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome

NCT05482334 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Difficulties enrolling participants due to study design

Conditions

Down Syndrome

Interventions

DRUG: Sargramostim for Injection
DRUG: Saline Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]